Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

PURPOSE: RTOG 0617 compared standard-dose (SD; 60 Gy) versus high-dose (HD; 74 Gy) radiation with concurrent chemotherapy and determined the efficacy of cetuximab for stage III non–small-cell lung cancer (NSCLC). METHODS: The study used a 2 × 2 factorial design with radiation dose as 1 factor and ce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Bradley, Jeffrey D., Hu, Chen, Komaki, Ritsuko R., Masters, Gregory A., Blumenschein, George R., Schild, Steven E., Bogart, Jeffrey A., Forster, Kenneth M., Magliocco, Anthony M., Kavadi, Vivek S., Narayan, Samir, Iyengar, Puneeth, Robinson, Clifford G., Wynn, Raymond B., Koprowski, Christopher D., Olson, Michael R., Meng, Joanne, Paulus, Rebecca, Curran, Walter J., Choy, Hak
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048161/
https://ncbi.nlm.nih.gov/pubmed/31841363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01162
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares